← Back to Patent Explorer
US3872127A Expired / Lapsed US ⏱️ 0.0 years remaining

N-(furyl- or thienyl-methyl)-14-oxy-7,8-dihydro-normorphinones and -norcodeinones and salts thereof

Assignee: C.H. Boehringer Sohn AG and Co KG
•
Filing: 1973-08-06
•
Granted: 1975-03-18
•
Expires: 1993-08-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula WHEREIN R1 is hydrogen, methyl or acetyl, R2 is hydrogen or acetyl, R3 is hydrogen or methyl, Q is oxygen, dimethoxy, diethoxy, ethylene-dioxy or propylene(1,3)dioxy, and X is oxygen or sulfur, AND NON-TOXIC, PHARMACOLOGICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF; THE COMPOUNDS AS WELL AS THEIR SALTS ARE USEFUL AS OPIATE-ANTAGONISTS.

Inventors

  • 👤 Herbert Merz
  • 👤 Adolf Langbein
  • 👤 Gerhard Walther
  • 👤 Klaus Stockhaus

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 07:55
CPC Classifications
C; C07; C07D; C07D489/00; C07D489/06; C07D489/08

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 5 words
A COMPOUND OF THE FORMULA
Claim 2
Dependent Claim 5 words
A COMPOUND OF THE FORMULA
Claim 3
Dependent Claim 10 words
A compound of claim 1, which is of the formula
Claim 4
Dependent Claim 10 words
A compound of claim 1, which is of the formula
Claim 5
Dependent Claim 10 words
A compound of claim 1, which is of the formula
Claim 6
Dependent Claim 17 words
A compound of claim 1, which is N-furfuryl-14-hydroxy-7,8-dihydro-normorphinone or a non-toxic, pharmacologically acceptable acid addition salt thereof.
Claim 7
Dependent Claim 17 words
A compound of claim 1, which is N-thenyl-14-hydroxy-7,8-dihydro-normorphinone or a non-toxic, pharmacologically acceptable acid addition salt thereof.
Claim 8
Dependent Claim 16 words
A compound of claim 1, which is N-(3''-thienylmethyl)-14-hydroxy-7,8-normorphinone or a non-toxic, pharmacologically acceptable addition salt thereof.
Claim 9
Dependent Claim 17 words
A compound of claim 1, which is N-furfuryl-14-hydroxy-7,8-dihydro-norcodeinone or a non-toxic, pharmacologically acceptable acid addition salt thereof.
Claim 10
Dependent Claim 17 words
A compound of claim 1, which is N-(3''-furylmethyl)-14-hydroxy-7,8-dihydro-norcodeinone or a non-toxic, pharmacologically acceptable acid addition salt thereof.
Claim 11
Dependent Claim 17 words
A compound of claim 1, which is N-(2''-methyl-3''-furylmethyl)-14-hydroxy-7,8-dihydro-norcodeinone or a non-toxic, pharmacologically acceptable acid addition salt thereof.

References Cited (Backward Citations)

US3793329A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-03-17 1978-09-16 1979-03-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-03-17 1982-09-16 1983-03-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-03-17 1986-09-16 1987-03-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag